Fifth Third Bancorp cut its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 4.4% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 486,132 shares of the healthcare conglomerate's stock after selling 22,253 shares during the period. UnitedHealth Group makes up about 0.9% of Fifth Third Bancorp's investment portfolio, making the stock its 20th largest holding. Fifth Third Bancorp owned about 0.05% of UnitedHealth Group worth $240,490,000 as of its most recent SEC filing.
Several other large investors have also recently added to or reduced their stakes in the business. Bray Capital Advisors boosted its stake in UnitedHealth Group by 0.5% during the 3rd quarter. Bray Capital Advisors now owns 9,616 shares of the healthcare conglomerate's stock valued at $4,848,000 after purchasing an additional 50 shares in the last quarter. Innova Wealth Partners grew its holdings in UnitedHealth Group by 2.9% during the third quarter. Innova Wealth Partners now owns 737 shares of the healthcare conglomerate's stock worth $372,000 after acquiring an additional 21 shares during the period. TFC Financial Management Inc. boosted its position in shares of UnitedHealth Group by 7.8% during the 3rd quarter. TFC Financial Management Inc. now owns 417 shares of the healthcare conglomerate's stock valued at $210,000 after purchasing an additional 30 shares in the last quarter. Rosenbaum Jay D. raised its holdings in shares of UnitedHealth Group by 44.6% in the 3rd quarter. Rosenbaum Jay D. now owns 823 shares of the healthcare conglomerate's stock worth $415,000 after purchasing an additional 254 shares in the last quarter. Finally, Baxter Bros Inc. boosted its holdings in UnitedHealth Group by 3.9% during the third quarter. Baxter Bros Inc. now owns 1,417 shares of the healthcare conglomerate's stock worth $714,000 after buying an additional 53 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling
In related news, EVP Erin Mcsweeney sold 1,236 shares of the business's stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares of the company's stock, valued at $4,527,306.72. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the firm's stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is owned by insiders.
UnitedHealth Group Stock Up 1.8 %
Shares of UNH stock traded up $8.86 on Thursday, hitting $492.97. The company's stock had a trading volume of 3,203,041 shares, compared to its average volume of 4,435,456. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $554.70. The firm's fifty day moving average price is $483.02 and its 200-day moving average price is $513.07. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79. The stock has a market capitalization of $453.57 billion, a price-to-earnings ratio of 30.13, a P/E/G ratio of 1.40 and a beta of 0.55.
UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating analysts' consensus estimates of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The business had revenue of $99.80 billion for the quarter, compared to the consensus estimate of $99.23 billion. During the same period last year, the business earned $6.26 EPS. The firm's revenue was up 8.6% compared to the same quarter last year. Research analysts anticipate that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.
UnitedHealth Group Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were given a $1.88 dividend. This represents a $7.52 annualized dividend and a dividend yield of 1.53%. The ex-dividend date was Friday, March 8th. UnitedHealth Group's dividend payout ratio is currently 45.97%.
Wall Street Analysts Forecast Growth
Several equities research analysts have recently weighed in on the company. Truist Financial reissued a "buy" rating and set a $600.00 price objective on shares of UnitedHealth Group in a research note on Wednesday, April 17th. Cantor Fitzgerald reaffirmed an "overweight" rating and set a $591.00 price objective on shares of UnitedHealth Group in a research note on Wednesday, April 10th. Deutsche Bank Aktiengesellschaft boosted their price target on shares of UnitedHealth Group from $545.00 to $562.00 and gave the company a "buy" rating in a report on Friday, April 19th. TD Cowen reduced their target price on UnitedHealth Group from $607.00 to $546.00 and set a "buy" rating for the company in a report on Wednesday, April 10th. Finally, Piper Sandler increased their price objective on UnitedHealth Group from $566.00 to $571.00 and gave the stock an "overweight" rating in a research note on Wednesday, April 17th. Four investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $570.05.
View Our Latest Report on UNH
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.
Download This Report
